All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drbergofficial on TikTok · 15s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @drbergofficial's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00lowered blood sugar. So this is really good to help stabilize someone if they have, if they're a prediabetic or diabetes or they have insulin resistance.
  2. 0:10So it's going to help your blood sugars. Why? Because the body is going to be running on ketones, not blood sugar.

MCT oil and blood sugar: what the evidence actually supports

Dr. Eric Berg

TikTok creator

15.4K viewsWatch on TikTok

Quick answer

MCT oil supplementation has been shown in controlled trials to modestly raise blood ketone levels and may be associated with small reductions in fasting glucose and insulin when substituted for long-chain dietary fats. However, these effects are not large enough or consistent enough to qualify MCT oil as a therapeutic intervention for prediabetes or type 2 diabetes management in current clinical guidelines. Patients managing blood glucose with medication should consult a provider before making significant dietary fat changes, as even modest metabolic shifts can affect drug efficacy and dosing needs.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 3 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For MCT oil and blood sugar: what the evidence actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

MCT oil and blood sugar: what the evidence actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "MCT oil and blood sugar: what the evidence actually supports" from Dr. Eric Berg. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: MCT oil supplementation has been shown in controlled trials to modestly raise blood ketone levels and may be associated with small reductions in fasting glucose and insulin when substituted for long-chain dietary fats.

The reason this review is not generic is the source wording and the canonical claim label "peptides benefit of mct oil lowered blood sugars drericberg mctoil bl." In this clip, the useful excerpt is: "lowered blood sugar." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Emerging pharmacotherapies for obesity: A systematic review (2025), Glucagon-like receptor agonists and next-generation incretin-based medications (2026), and Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

MCT supplementation raises blood ketone levels, a mechanism confirmed by Croteau et al.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

MCT oil supplementation has been shown in controlled trials to modestly raise blood ketone levels and may be associated with small reductions in fasting glucose and insulin when substituted for long-chain dietary fats.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • MCT oil supplementation has been shown in controlled trials to modestly raise blood ketone levels and may be associated with small reductions in fasting glucose and insulin when substituted for long-chain dietary fats. However, these effects are not large enough or consistent enough to qualify MCT oil as a therapeutic intervention for prediabetes or type 2 diabetes management in current clinical guidelines. Patients managing blood glucose with medication should consult a provider before making significant dietary fat changes, as even modest metabolic shifts can affect drug efficacy and dosing needs.
  • A 2021 meta-analysis of 29 trials (Rial et al., Nutrients) found MCT oil produces modest fasting glucose reductions compared to long-chain fats, but results were inconsistent across studies.
  • MCT supplementation raises blood ketone levels, a mechanism confirmed by Croteau et al. (2018, Alzheimer's and Dementia), but this does not mean the body stops using glucose as a fuel source.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • A 2021 meta-analysis of 29 trials (Rial et al., Nutrients) found MCT oil produces modest fasting glucose reductions compared to long-chain fats, but results were inconsistent across studies.
  • MCT supplementation raises blood ketone levels, a mechanism confirmed by Croteau et al. (2018, Alzheimer's and Dementia), but this does not mean the body stops using glucose as a fuel source.
  • There are no clinical trials demonstrating MCT oil alone is sufficient to stabilize blood sugar in people with diagnosed diabetes or prediabetes.
  • People with impaired metabolism, including type 2 diabetes, may have reduced capacity to convert MCTs into ketones, weakening Berg's core mechanism argument.
  • MCT oil is calorie-dense, roughly 100 calories per tablespoon, meaning unchecked use can add energy intake in a population where caloric balance already matters.
  • If you take glucose-lowering medications, any dietary change that affects insulin sensitivity should be discussed with a provider before implementation.
  • Berg's biochemistry is directionally accurate; his clinical confidence is not supported by the current evidence base.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @drbergofficial actually say?

Berg's claim is short and confident: MCT oil lowers blood sugar, and the reason is that "the body is going to be running on ketones, not blood sugar." He frames this as useful for prediabetes, diabetes, and insulin resistance. That's a lot of therapeutic weight to put on a dietary fat supplement, and the mechanism he describes is real but incomplete to the point of being misleading.

He isn't claiming MCT oil is a drug or a cure. The framing is more like a metabolic workaround: use fat-derived ketones as fuel and you'll need less glucose. That logic has some grounding in research, but Berg presents it as cause-and-effect when the evidence is considerably more conditional than that.

Does the science back this up?

Partially, yes. MCT oil does influence blood glucose and insulin dynamics, but the effect size is modest and context-dependent. It is not a reliable standalone intervention for diabetes management.

A 2018 randomized controlled trial by Croteau et al. in the journal Alzheimer's and Dementia found MCT supplementation raised blood ketone levels meaningfully, which confirms the ketone-production mechanism Berg describes. On the glucose side, a 2021 meta-analysis by Rial et al. in Nutrients reviewed 29 trials and found MCT consumption was associated with modest reductions in fasting glucose and insulin levels compared to long-chain triglycerides, but the effects were not consistent across all studies and were often small in absolute terms.

The "running on ketones, not blood sugar" framing is an oversimplification. The body doesn't fully switch fuel sources from a tablespoon of MCT oil. Ketone levels rise, but you're not in nutritional ketosis from MCT supplementation alone. Glucose metabolism continues in parallel.

What did they get wrong (or right)?

Berg gets the mechanism directionally right but overstates how cleanly it works. The idea that MCTs produce ketones is accurate. The idea that this meaningfully "stabilizes" someone with diabetes is where the claim runs ahead of the evidence.

People with type 2 diabetes and insulin resistance can have impaired ketone metabolism too, which complicates the "run on ketones instead" logic. A 2020 paper by Cunnane et al. in Frontiers in Aging Neuroscience noted that MCT-derived ketone production can be blunted in metabolically compromised individuals.

What's missing entirely from Berg's 30-second clip is any acknowledgment that: MCT oil adds significant calories, which matters for metabolic health; the blood sugar effects seen in studies typically accompany broader dietary changes; and people on diabetes medications face real risks from unmonitored glucose changes. Recommending MCT oil to diabetics without those caveats is irresponsible, even if the core chemistry isn't wrong.

  • Ketone production from MCTs: supported by evidence
  • Modest glucose reduction: supported but overstated
  • Sufficient to "stabilize" diabetics: not supported as a standalone claim

What should you actually know?

MCT oil is not a blood sugar medication. If you have prediabetes, diabetes, or insulin resistance, it should be thought of as a dietary component within a broader strategy, not a fix. The research suggests it may offer modest metabolic benefits when substituted for long-chain fats, particularly in the context of a lower-carbohydrate diet, but it does not replace medication, monitoring, or physician oversight.

If you're on insulin or any glucose-lowering medication, adding MCT oil without telling your provider is a bad idea. Not because MCT oil is dangerous, but because even small shifts in glucose dynamics can affect how your medication performs.

Berg's video is the kind of content that oversimplifies a real but nuanced finding into something that sounds like a prescription. It isn't one. The underlying biochemistry is real. The clinical leap he makes is not backed by current evidence at the level of confidence he implies.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Eric Berg · TikTok creator

15.4K views on this video

Benefit of MCT Oil: Lowered Blood Sugars #drericberg #mctoil #bloodsugar #ketones #health

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about a 2021 meta-analysis of 29 trials (rial et al., nutrients)?

A 2021 meta-analysis of 29 trials (Rial et al., Nutrients) found MCT oil produces modest fasting glucose reductions compared to long-chain fats, but results were inconsistent across studies.

What does the video say about mct supplementation raises blood ketone levels, a mechanism confirmed by?

MCT supplementation raises blood ketone levels, a mechanism confirmed by Croteau et al. (2018, Alzheimer's and Dementia), but this does not mean the body stops using glucose as a fuel source.

What does the video say about there?

There are no clinical trials demonstrating MCT oil alone is sufficient to stabilize blood sugar in people with diagnosed diabetes or prediabetes.

What does the video say about people with impaired metabolism, including type 2 diabetes, may have?

People with impaired metabolism, including type 2 diabetes, may have reduced capacity to convert MCTs into ketones, weakening Berg's core mechanism argument.

What does the video say about mct oil?

MCT oil is calorie-dense, roughly 100 calories per tablespoon, meaning unchecked use can add energy intake in a population where caloric balance already matters.

What does the video say about if you take glucose-lowering medications, any dietary change?

If you take glucose-lowering medications, any dietary change that affects insulin sensitivity should be discussed with a provider before implementation.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. Eric Berg, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.